sIL in Medical Technology

Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

... LOS ANGELES, Aug. 7 /PRNewswire-USNewswire/ -- A new drug delivery system that uses a tiny silicone cup filled with any drug and sealed to the outer surface (episclera) of the eyeball may offer a more effective method for the sustained delivery...

Mayo Clinic Proceedings: A Comprehensive Review of Addiction to Prescription Painkillers Among Patients and Physicians

...rding to Dr. Passik. In "A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain," Charles Argoff, M.D., and Daniel silvershein, M.D., both from the Department of Neurology, Albany Medical College , N.Y., write that management of chronic non-cancer pain, for example, ...

Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)

...g, a precisely defined droplet size, and a high proportion of respirable droplets delivered in the shortest possible period of time. Combined with its silent mode of operation, small size (it fits in the palm of the hand), light weight, and battery use, products incorporating eFlow Technology reduce the...

Alfacell Provides Shareholder Update

...tside of the clinical and regulatory arena. One such experiment we are looking into is whether Onconase can be used as routine tool to detect the gene silencing via RNA interference (RNAi) mechanism. Currently, there are thousands of researchers interested in finding the answer about the RNAi-mediated ...

Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily

... Data Findings Published in June Issue of Circulation silVER SPRING, Md. and INDIANAPOLIS, June 9 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) and Eli Lilly and Company (NYSE: ...

Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting

...complexing proteins) is efficacious and well-tolerated in upper limb spasticity of various etiologies authored by Barnes, M., Schnitzler, A., Amaral e silva, A., Aquilar, M., Lehnert-Batar, A., and Minnasch, P. Method Responder analysis of at least 1-point improvement from baseline to week 4 on...

PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans

...g, a precisely defined droplet size, and a high proportion of respirable droplets delivered in the shortest possible period of time. Combined with its silent mode of operation, small size (it fits in the palm of your hand), light weight, and battery use, products incorporating eFlow Technology reduce th...

FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension

... Conference Call to be Held at 9:00 a.m. Eastern Time Today, May 26, 2009 silVER SPRING, Md., May 26 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) announced today that the United States Food and Dr...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

...g, a precisely defined droplet size, and a high proportion of respirable droplets delivered in the shortest possible period of time. Combined with its silent mode of operation, small size (it fits in the palm of your hand), light weight, and battery use, products incorporating eFlow Technology reduce th...

Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala

... In addition to the award presentations, the Hearts & Heroes Gala will include a cocktail and hors d'oeuvres reception, seated dinner, live and silent auctions, and dancing to the sounds of The Marsels. FOX25 News Anchors Maria Stephanos and Mark Ockerbloom will serve as event emcees. Ab...

Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study

... Largest Study to Date Will Evaluate silverHawk Plaque Excision System for Treatment of Lo...mediate and long-term effectiveness of stand-alone silverHawk(R) Plaque Excision therapy for endovascula...com.com/cgi-bin/prnh/20090430/NY08452 ) "The silverHawk Plaque Excision System offers patients an ...

Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R)

...e enrolled with VLUs that had not healed with other advanced wound care modalities - including the gold standard multi-layered compression, as well as silver antimicrobial dressings, hyperbaric oxygen therapy, and antibiotic therapy - for at least 4 months' duration. The study was designed to measure t...

Cequent tkRNAi Technology to be Presented at the Centennial Meeting of the American Association for Cancer Research

...iple genes Abstract # LB-38 simultaneously and induce significant gene silencing. Data presented here targets oncogenes relevan... 1 - 5 pm Hall B-F Cequent's Director of Development, Alison silva, will Poster Section 15 present novel data showing the safety and ef...

American Lung Association Study to be Published in the 'New England Journal of Medicine' Finds Prescription Heartburn Medication Does Not Control Asthma Symptoms as Previously Thought

...n Lung Association Chief Medical Officer. "Now we know with confidence that silent acid reflux does not play a significant role in poor asthma control. Ta...led asthma, treatment with proton pump inhibitors does not improve control. silent GER is not a likely cause of poorly controlled asthma. Norman H. E...

Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes

... silVER SPRING, Md., April 2 /PRNewswire-FirstCall/ -- Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the ...

Nation's Laboratory Response Network Marks First Decade of Protecting Public Health

... silVER SPRING, Md., March 30 /PRNewswire-USNewswire/ -- The Laboratory Respons... ublic Health Labo r atories is a national non-profit located i n silver Spring, MD, that is dedicated to working with m e mbers to str ...

Astrocytes Help Separate Man From Mouse

...h conventional techniques, they witnessed no activity. Rather than realizing their tools were incomplete, scientists assumed that astrocytes were silent. So Nedergaard devised a new way to "listen" for astrocyte activity, developing a sophisticated laser system to look at their activity by mea...

Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update

...mended and restated loan facility with GE Healthcare Financial Services and silicon Valley Bank. New CFO: In February 2009,... maintain under its loan facility with GE Healthcare Financial Services and silicon Valley Bank and the Company's projected operating results, the Company...

Quark Pharmaceuticals Presents at Asia TIDES Conference

...) following major cardiac surgery and of delayed graft function in kidney transplantation. For the structure of these products Quark has licenses from silence Therapeutics and from Alnylam Pharmaceuticals. QPI-1007, a siRNA that utilizes a proprietary structure developed by Quark, is being evalua...

Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis

...onal battle. "I realized that I had to get the message out that regardless of how healthy you think you are, you may be walking around with this silent killer. I was surprised that this could happen to me - after all, I've worked out my whole life. But heart disease and stroke can strike anyone,"...

Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures

... regulatory milestones with less reliance on other sources of capital. Cato BioVentures has offices in Boston's Bay Colony, Research Triangle Park and silicon Valley. www.catobioventures.com About Cordex Pharma, Inc. Cordex is a specialty pharmaceutical company that develops new cardiovascul...

MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series

...ling venous leg ulcers. These wounds had previously failed to heal while being managed with such therapeutic modalities as multi-layered compression, silver antimicrobial dressings, antibiotic therapy, and hyperbaric oxygen. Six of the wounds completely healed within 4 weeks, and all eleven wounds hea...

New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide

...d the following statement on the results of the Phase II/IIb safety and effectiveness study of BufferGel and PRO2000 (0.5 percent concentration): silVER SPRING, Md., Feb. 9 /PRNewswire/ -- The Microbicide Trials Network, a worldwide collaborative group funded by the US National Institutes of Health...

Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs

.... In distinct contrast, the majority of these genes were down-regulated or silenced in the human-animal hybrids. "We examined the factors recently u...rence or a down-regulation of these critical pluripotency genes effectively silencing them--thus making the generation of stem cells impossible. Without ...

Impact Medical Solutions Announces Appointment of New Director and Corporate Update

...isory services to small-cap companies. He is also the President and CEO of Orex Exploration Inc., a junior gold exploration company, and CEO of Argex silver Capital Inc., a Capital Pool Company. Mr. Billings is active as a Director and advisor to several private and public corporations. He received a...

Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding

...Aalst. The trial's steering committee also includes Dr. William Wijns, co-Director of the Cardiovascular Center Aalst, and Prof. Michal Tendera of the silesian Heart Centre, Katowice, a past president of the European Society of Cardiology. Dr. Desire Collen, Chairman and CEO of Life Science Resea...

Gene Marker May Improve Odds of Stem Cell Therapies for Disease

...o Institute for Cancer Research and Molecular Medicine at Temple University . "Next we will work to confirm our data by seeing the impact when Rb2 is silenced in these stem cells." The Human Health Foundation (HHF) ( www.hhfonlus.org ) is a nonprofit organization designed to develop and fund biome...

Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function

... p53 to protect normal cells from acute injury. QPI-1002 is a chemically modified siRNA discovered by Quark with structure covered under licenses from silence Therapeutics and from Alnylam Pharmaceuticals. QPI-1002 was the first systemically administered siRNA in a human clinical study. About Qu...

'We're Ready to Prove It!'

... Brigitte Boisselier breaks 5-year silence, offers to ease cloning costs for Clonaid clients willing to go public LAS VEGAS, Dec. 27 /PRNewswire-USNewswire/ -- Six years to the day af...

Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis

...bited by SYI-2074. About Psoriasis Psoriasis is an immune-mediated chronic inflammatory disease usually characterized by red lesions or silvery white scales on the skin, which usually occur on the scalp, knees, elbows, the abdomen (around the navel) and the genitals. In about a quarter of...

Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting

...his study are consistent with the guideline's recommendations," said Samuel silver, M.D., Chair of the ASH Subcommittee on Reimbursement, and Professor of...mine whether any updates should be made as a result of these new data." Dr. silver will be available at the ASH press conference on treatment advances in ...

Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder

...s and save lives. One of the key stories featured is that of Alexandria, a teenage girl being treated for sickle cell anemia who previously suffered a silent stroke; her hematologist, Michael DeBaun, MD, who is featured in the film, along with Dr. Berliner, who was a scientific advisor for the documenta...

Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD

...kin, D.P., Rennard, S.I., Martin, P., Goldman, M., silkoff, P.E. Efficacy of Budesonide/Formoterol Admin...kin, D.P., Rennard, S.I., Martin, P., Goldman, M., silkoff, P.E. Tolerability of Budesonide and Formoter... S.I., Tashkin, D.P., McElhattan, J., Goldman, M., silkoff, P.E. Long-term Efficacy of Budesonide/Formot...

Lutonix Inc. Announces $20 Million Series B Financing

...anies have either completed an initial public offering or have been acquired by a leading healthcare corporation. U.S. Venture Partners is a leading silicon Valley-based, early stage venture capital fund founded in 1981. The firm manages over $3.0 billion across ten venture funds and is currently inve...

Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults

...stration is not recommended with indinavir, lopinavir/ritonavir, saquinavir, and pravastatin. Caution should be used when prescribing agents such as sildenafil, vardenafil, tadalafil, or other substrates, inhibitors, or inducers of CYP3A in patients receiving PREZISTA/r. This list of potential drug in...

Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology

...ion of Reprogramming to Ground State Pluripotency by Signal Induction. silva, J. et al. (2008) PLoS Biol 6(10): e253 doi:10.1371/journal.pbio.00...ion of Reprogramming to Ground State Pluripotency by Signal Induction. silva, J. et al. (2008) PLoS Biol 6(10): e253 doi:10.1371/journal.pbio.00...

ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver

... with graft donor sites treated with Altrazeal(TM) silver compared with a market leading silver containing carboxymethylcellulose dressing. Th...designed to support the marketing of Altrazeal(TM) silver and provide the necessary clinical data to app...

Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children

...Release, go to: http://www.prnewswire.com/mnr/nhlbiclinicalstudies/35258/ In June, the main 10-minute video earned three Telly awards, including a silver (the highest award) in education. The prestigious Tellys honor outstanding local, regional, and cable TV commercials and programs; film and video ...

Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain

...er than waiting for it to occur," explained Steven silverstein, M.D. of silverstein Eye Centers. Dr. Silverstein was a princi...on with a favorable safety profile," commented Dr. silverstein. "It is a welcome improvement to the arma...

Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures

...n into active service. Agenda: 9:00 - 9:45 a.m. AmeriCorps member and guest shall begin to arrive; 10:00 - 10:25 a.m. - Opening with a Moment of silence and The American Tradition of Service from the Members' Handbook - Charlene Arcila 10:30 - 10:45 a.m. - Welcoming Remarks: TPAC ACTS AmeriCorps...